Calcification of bicuspid aortic valves

Heart

Volumn 88, Issue 4, 2002, Pages 321-322

  Otto, Catherine ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE DISEASE; ATHEROSCLEROSIS; CALCIFICATION; HUMAN; INFLAMMATION; MECHANICAL STRESS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0036785973     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.4.321     Document Type: Short Survey

References (16)

1. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histologic and immunohistochemical studies. Circulation 1994;90:844-53.
2. Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-70.
3. Olsson M, Thyberg J, Nilsson J. Presence of oxidized Iow density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-22.
4. O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B, (a) and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis. Arterioscler Thromb 1996;16:523-32.
5. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-8.
6. Mohler ER, III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
7. Ghaisas NK, Foley JB, O'Briain DS, et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol 2000;36:2257-62.
8. Edep ME, Shirani J, Wolf P, et al. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000;9:281-6.
9. Muller AM, Cronen C, Kupferwasser LI, et al. Expression of endothelial cell adhesion molecules on heart valves: up regulation in degeneration as well as acute endocarditis. J Pathol 2000;191:54-60.
10. Jian B, Jones PL, Li Q, et al. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001;159:321-7.
11. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630-4.
12. Boon A, Cheriex E, Lodder J, et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-4.
13. Beppu S, Suzuki S, Matsuda H, et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol 1993;71:322-7.
14. Wallby L, Janerot-Sjöberg B, Steffensen T, et al. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002;88:348-51.
15. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 1997;30:1809-12.
16. Chan KL, Ghani M, Woodend K, et al. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol 2001;88:690-3.